Angiographic demonstration of inhibition of methyl-ergonovine-induced coronary vasospasm in a patient with sudden death.
A case is presented illustrating the association of spontaneous coronary vasospasm with sudden death. Serial angiography and challenge with methyl-ergonovine were performed to document the effectiveness of medial therapy. The use and safety of ergonovine testing in patients with spasm-related sudden death are reviewed.